Loading clinical trials...
Loading clinical trials...
Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung "Early Detection of Lung Cancer Based on Small RNA Signatures - Boston II"
Conditions
Interventions
miLungDx
Locations
8
United States
Northside Hospital
Atlanta, Georgia, United States
Mass General Brigham
Boston, Massachusetts, United States
Henry Ford Health
Detroit, Michigan, United States
Jacobi Medical Center
The Bronx, New York, United States
New York Health + Hospitals
The Bronx, New York, United States
Duke University Health System
Durham, North Carolina, United States
Start Date
October 18, 2023
Primary Completion Date
October 1, 2024
Completion Date
December 1, 2025
Last Updated
January 16, 2024
NCT05671510
NCT06257264
NCT06498635
NCT03563976
NCT03872661
NCT06646276
Lead Sponsor
Hummingbird Diagnostics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions